Relationship Between Patient Characteristics and Severity With the Use of Antiviral Drugs Among Covid-19 Patients at Rumah Sakit Ichsan Medical Centre Bintaro
{"title":"Relationship Between Patient Characteristics and Severity With the Use of Antiviral Drugs Among Covid-19 Patients at Rumah Sakit Ichsan Medical Centre Bintaro","authors":"Gina Aulia, Humaira Fadhilah, Tania Rizki Amalia, Fenita Purnama Sari Indah, Nurihardianti Nurihardianti, Sintia Sintia, Sandeep Poddar","doi":"10.47836/mjmhs.19.s9.18","DOIUrl":null,"url":null,"abstract":"Introduction: Coronavirus Disease 2019 (COVID-19) is a pandemic infectious disease caused by SARS-CoV-2 that was declared in March 2020. The goal of this study was to see if there was a link between patient characteristics (age, gender) and patient severity with the use of Covid-19 antiviral drugs in Covid-19 patients hospitalized at Rumah Sakit Ichsan Medical Center Bintaro between July and December 2021. Methods: Through retrospective data tracing, this study employed an analytical observational method with a cross sectional design. The research data was gathered from Covid-19’s medical records. With purposive sampling, the number of respondents as a sample reached 107 patients. Results: The results showed that the age range of most Covid-19 patients was 26–45 years old by 46.7%, males were more exposed to Covid-19 by 52.3%, the highest degree of severity was included in the mild category, namely 62.6%, and the highest use of antiviral was favipiravir at 70.1%. The analysis revealed that there was no significant relationship between age (p value = 0.346) and gender (p value = 0.387) with the use of Covid-19 antiviral drugs, but there was a significant relationship between patient everity and antiviral drug use (p value = 0.005). Conclusion: Finally, there is no significant relationship between age and gender with the use of Covid-19 antiviral drugs, while between the severity of patients there is a significant relationship with the use of Covid-19 antiviral drugs.","PeriodicalId":40029,"journal":{"name":"Malaysian Journal of Medicine and Health Sciences","volume":"23 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Malaysian Journal of Medicine and Health Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47836/mjmhs.19.s9.18","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Coronavirus Disease 2019 (COVID-19) is a pandemic infectious disease caused by SARS-CoV-2 that was declared in March 2020. The goal of this study was to see if there was a link between patient characteristics (age, gender) and patient severity with the use of Covid-19 antiviral drugs in Covid-19 patients hospitalized at Rumah Sakit Ichsan Medical Center Bintaro between July and December 2021. Methods: Through retrospective data tracing, this study employed an analytical observational method with a cross sectional design. The research data was gathered from Covid-19’s medical records. With purposive sampling, the number of respondents as a sample reached 107 patients. Results: The results showed that the age range of most Covid-19 patients was 26–45 years old by 46.7%, males were more exposed to Covid-19 by 52.3%, the highest degree of severity was included in the mild category, namely 62.6%, and the highest use of antiviral was favipiravir at 70.1%. The analysis revealed that there was no significant relationship between age (p value = 0.346) and gender (p value = 0.387) with the use of Covid-19 antiviral drugs, but there was a significant relationship between patient everity and antiviral drug use (p value = 0.005). Conclusion: Finally, there is no significant relationship between age and gender with the use of Covid-19 antiviral drugs, while between the severity of patients there is a significant relationship with the use of Covid-19 antiviral drugs.
期刊介绍:
The Malaysian Journal of Medicine and Health Sciences (MJMHS) is published by the Faculty of Medicine and Health Sciences, Universiti Putra Malaysia. The main aim of the MJMHS is to be a premier journal on all aspects of medicine and health sciences in Malaysia and internationally. The focus of the MJMHS will be on results of original scientific research and development, emerging issues and policy analyses pertaining to medical, biomedical and clinical sciences.